Taken together, these findings suggest that different mechanisms are involved in the dysregulation of ANGPTL3 and ANGPTL4 in patients with increased adiposity or, alternatively, that diverse metabolic abnormalities stem from the obesity-associated changes in circulating ANGPTL3 and ANGPTL4. Here, ANGPTL4 is linked to obesity disorder.